When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. That said, here are three stocks facing legitimate challenges and some alternatives worth exploring instead.

Keurig Dr Pepper (KDP)

Consensus price target: $36.38 (3.8% implied return)

Born out of a 2018 merger between Keurig Green Mountain and Dr Pepper Snapple, Keurig Dr Pepper (NASDAQ: KDP) is a consumer staples powerhouse boasting a portfolio of beverages including sodas, coffees, and juices.

Why Are We Wary of KDP?

1. Free cash flow margin has stayed in place over the last year
2. Below-average returns on capital indicate management struggled to find compelling investment opportunities
3. High net-debt-to-EBITDA ratio of 5× could force the company to raise capital on unfavorable terms if market conditions deteriorate

Keurig Dr Pepper’s stock price of $35.04 implies a valuation ratio of 14.3x forward P/E. Dive into our free research report to see why there are better opportunities than KDP.

Zions Bancorporation (ZION)

Consensus price target: $72.64 (10.2% implied return)

Founded in 1873 during Utah's pioneer era and named after Mount Zion in the Bible, Zions Bancorporation (NASDAQ: ZION) operates seven regional banks across the Western United States, providing commercial, retail, and wealth management services to over a million customers.

Why Are We Hesitant About ZION?

1. Muted 4.2% annual net interest income growth over the last five years shows its demand lagged behind its banking peers
2. Performance over the past five years shows its incremental sales were less profitable as its earnings per share were flat
3. Capital trends were unexciting over the last five years as its 1.5% annual tangible book value per share growth was below the typical banking firm

At $65.94 per share, Zions Bancorporation trades at 1.2x forward P/B. Check out our free in-depth research report to learn more about why ZION doesn’t pass our bar.

Home Bancshares (HOMB)

Consensus price target: $32.75 (8.9% implied return)

Founded in Conway, Arkansas in 1998 and growing through strategic acquisitions across the Southeast, Home Bancshares (NYSE: HOMB) operates as the bank holding company for Centennial Bank, providing commercial and retail banking services to businesses and individuals across multiple states.

Why Do We Think Twice About HOMB?

1. Annual revenue growth of 6.7% over the last two years was below our standards for the banking sector
2. Estimated net interest income growth of 4% for the next 12 months implies demand will slow from its five-year trend
3. Annual earnings per share growth of 6% underperformed its revenue over the last five years, showing its incremental sales were less profitable

Home Bancshares is trading at $30.08 per share, or 1.3x forward P/B. To fully understand why you should be careful with HOMB, check out our full research report (it’s free).

High-quality stocks for all market conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.